Société Algérienne De Formation Et Recherche En Oncologie

This study follows 1,000 people with HER2-positive breast cancer to see how a biosimilar version of pertuzumab is used in everyday care. It looks at treatment patterns, tumor response, and side effects in two groups: those getting the drug before surgery and those receiving it as…

This study aims to describe the features of gastric cancer in 1,000 patients in Algeria, including their demographics, risk factors, symptoms, and how the disease is diagnosed and treated. Researchers will collect data from medical records and follow patients over time to underst…

This study aims to describe the characteristics of prostate cancer in Algeria, including patient demographics, symptoms, diagnosis methods, and treatments. Researchers will collect information from 2,000 patients aged 19 and older with confirmed prostate cancer. The goal is to be…